Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

Similar articles for PubMed (Select 23668912)

1.

Left atrial appendage occlusion: single center experience with PLAATO LAA Occlusion System(®) and AMPLATZER™ Cardiac Plug.

Helsen F, Nuyens D, De Meester P, Rega F, Budts W.

J Cardiol. 2013 Jul;62(1):44-9. doi: 10.1016/j.jjcc.2013.02.019. Epub 2013 May 11.

2.

Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.

Streb W, Szymała M, Kukulski T, Nowak J, Lekston A, Sokal A, Knapik P, Czapla J, Zbieralska E, Kalarus Z.

Kardiol Pol. 2013;71(1):8-16.

3.

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H.

J Am Coll Cardiol. 2005 Jul 5;46(1):9-14.

4.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.

J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6. doi: 10.1016/j.jacc.2013.03.035. Epub 2013 Apr 10.

5.

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.

Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.

Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.

PMID:
23973952
6.

Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series.

Danna P, Proietti R, Sagone A, Arensi A, Viecca M, Rago A, Russo V.

Pacing Clin Electrophysiol. 2013 Mar;36(3):347-53. doi: 10.1111/pace.12058. Epub 2012 Dec 17.

PMID:
23252940
7.

Left atrial appendage occlusion: initial experience with the Amplatzer™ Amulet™.

Freixa X, Abualsaud A, Chan J, Nosair M, Tzikas A, Garceau P, Basmadjian A, Ibrahim R.

Int J Cardiol. 2014 Jul 1;174(3):492-6. doi: 10.1016/j.ijcard.2014.03.154. Epub 2014 Mar 28.

PMID:
24820753
9.

Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.

Faustino A, Paiva L, Providência R, Trigo J, Botelho A, Costa M, Leitão-Marques A.

Rev Port Cardiol. 2013 Jun;32(6):461-71. doi: 10.1016/j.repc.2012.10.011. Epub 2013 Apr 30. English, Portuguese.

PMID:
23639325
10.

Ad hoc percutaneous left atrial appendage closure.

Nietlispach F, Krause R, Khattab A, Gloekler S, Schmid M, Wenaweser P, Windecker S, Meier B.

J Invasive Cardiol. 2013 Dec;25(12):683-6.

11.

Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study.

Swaans MJ, Post MC, Rensing BJ, Boersma LV.

J Am Heart Assoc. 2012 Oct;1(5):e002212. doi: 10.1161/JAHA.112.002212. Epub 2012 Oct 25.

12.

Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.

Park JW, Leithäuser B, Gerk U, Vrsansky M, Jung F.

J Invasive Cardiol. 2009 Sep;21(9):446-50.

13.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

14.

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.

Ussia GP, Mulè M, Cammalleri V, Scarabelli M, Barbanti M, Immè S, Mangiafico S, Marchese A, Galassi AR, Tamburino C.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):217-22. doi: 10.1002/ccd.22099.

PMID:
19472361
15.

Percutaneous left atrial appendage closure for stroke prevention.

De Backer O, Loupis AM, Ihlemann N, Vejlstrup NG, Søndergaard L, Franzen OW.

Dan Med J. 2014 Aug;61(8):A4879.

PMID:
25162439
16.

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV.

J Vis Exp. 2013 Feb 26;(72):e3818. doi: 10.3791/3818.

17.

Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.

Wiebe J, Bertog S, Franke J, Wettstein O, Lehn K, Hofmann I, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2014 Apr 1;83(5):796-802. doi: 10.1002/ccd.25329. Epub 2014 Jan 8.

PMID:
24327462
18.
19.

Amplatzer left atrial appendage occlusion: single center 10-year experience.

Nietlispach F, Gloekler S, Krause R, Shakir S, Schmid M, Khattab AA, Wenaweser P, Windecker S, Meier B.

Catheter Cardiovasc Interv. 2013 Aug 1;82(2):283-9. doi: 10.1002/ccd.24872. Epub 2013 Mar 22.

PMID:
23412815
20.

Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure.

Mínguez JR, Asensio JM, Gragera JE, Costa M, González IC, de Carlos FG, Díaz JA, Martín Yuste V, González RM, Domínguez-Franco A, Buendía AB, Garibi JH, Hernández FH, Ribeiro VG.

Heart. 2015 Jun;101(11):877-83. doi: 10.1136/heartjnl-2014-306332. Epub 2015 Jan 8.

PMID:
25573984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk